Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation

Annals of Thoracic Surgery

Volumn 93, Issue 2, 2012, Pages 366-371

  Hartwig, Matthew G ^a   Walczak, Richard ^a   Lin, Shu S ^a   Davis, R Duane ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLOODSTREAM INFECTION; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; EXTRACORPOREAL OXYGENATION; FEMALE; FIBROSING ALVEOLITIS; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIOSIS; MYCOSIS; POST TREATMENT SURVIVAL; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; SPIROMETRY; TRANSBRONCHIAL BIOPSY;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NORTH CAROLINA; POSTOPERATIVE CARE; PRIMARY GRAFT DYSFUNCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84862909290     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.05.017     Document Type: Article

References (11)

1. G. Thabut, I. Vinatier, J.B. Stern Primary graft failure following lung transplantation: predictive factors of mortality Chest 121 2002 1876 1882
2. J.D. Christie, R.M. Kotloff, A. Pochettino Clinical risk factors for primary graft failure following lung transplantation Chest 124 2003 1232 1241
3. J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official lung and heart-lung transplant report2010 J Heart Lung Transplant 29 2010 1104 1118
4. M.O. Meade, J.T. Granton, A. Matte-Martyn A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation Am J Respir Crit Care Med 167 2003 1483 1489
5. S. Keshavjee, R.D. Davis, M.R. Zamora A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings J Thorac Cardiovasc Surg 129 2005 423 428
6. J.D. Christie, M. Carby, R. Bag Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part II: definition A consensus statement of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 24 2005 1454 1459
7. B.F. Meyers, T.M. Sundt, S. Henry Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation J Thorac Cardiovasc Surg 120 2000 20 26
8. L.R. Glassman, R.J. Keenan, M.C. Fabrizio Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients J Thorac Cardiovasc Surg 110 1995 723 727
9. M.G. Hartwig, J.Z. Appel, E. Cantu Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation Ann Thorac Surg 80 2005 1872 1879
10. C.A. Bermudez, P.S. Adusumilli, K.R. McCurry Extracorporeal membrame oxygenation for primary graft dysfunction after lung transplantation: long-term survival Ann Thorac Surg 87 2009 854 860
11. R.C. King, O.A. Binns, F. Rodriguez Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 2000 1681 1685